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We have shown that mitochondrial c-Src regulates reactive oxygen species (ROS) production by
phosphorylating the succinate dehydrogenase A of respiratory complex II (CxII). To elucidate the
molecular mechanisms underlying ROS production regulated by c-Src in the CxII, we investigated
the CxII protein complex derived from cells treated with Src family kinase inhibitor PP2. We iden-
tiﬁed ﬂotillin-1 as a c-Src target that prevents ROS production from CxII. Phosphorylation-site anal-
ysis suggests Tyr56 and Tyr149 on ﬂotillin-1 as sites for phosphorylation by c-Src. A comparison of
cells expressing ﬂotillin-1 and its phosphorylation defective mutants conﬁrms the requirement for
ﬂotillin-1 phosphorylation for its interaction with CxII and subsequent reduction in ROS production.
Our ﬁndings suggest a critical role of ﬂotillin-1 in ROS production mediated by c-Src.
Structured summary of protein interactions:
SDHA, SDHB, SDHC, SDHD, ﬂotillin-2 and ﬂotillin-1, EMI5, TUFM, ANT2, ATP5A1, PHB, ATP5B, GRP75
and HSP60 physically interact by anti bait coip (View interaction)
ﬂotillin-1, cytochrome c and ﬂotillin-2 colocalize by cosedimentation through density gradient (View
interaction)
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Mitochondrial protein phosphorylation is an important mecha-
nism for the modulation of mitochondrial function. The results of
the mitochondrial Ser/Thr phosphoproteome have been reported
[1,2], and the phosphorylation of tyrosine has also been implicated
in mitochondrial regulation, in which the energy production sys-
tem of a cell is regulated by the modiﬁcation of mitochondrial pro-
teins [3–5]. Several non-receptor-type and receptor-type tyrosine
kinases including c-Src, Fyn, Lyn, Fgr, C-terminal Src kinase, Abl
and EGFR have been observed in mitochondria [6–8], and Srcfamily kinases (SFKs) are major agents in mitochondrial tyrosine
phosphorylation [8]. We have previously demonstrated that c-Src
activity is required for effective energy production by the oxidative
phosphorylation system, and for the suppression of reactive oxy-
gen species (ROS) generation. Particularly, c-Src phosphorylates
NADH dehydrogenase (ubiquinone) ﬂavoprotein 2 (NDUFV2) at
Tyr193 in respiratory complex I (CxI), which is indispensable for
NADH dehydrogenase activity and ATP production, and succinate
dehydrogenase A (SDHA) at Tyr215 in CxII, which is required for
the prevention of ROS production and for cell survival [9]. In addi-
tion, c-Src has been reported to be required for the activity of com-
plex IV via the direct phosphorylation of its subunit II [5].
Although c-Src activity is regulated by intracellular ROS through
the oxidation of several cysteine residues [10,11], recent studies
have suggested that c-Src also regulates ROS production in local-
ized subcellular districts including mitochondria [12,13]. The
respiratory chain is a major endogenous source of mitochondrial
ROS such as superoxide anion (O2) and hydrogen peroxide
(H2O2) [14,15]. Although respiratory CxI and CxIII have long been
recognized as a main pathway of ROS supply [16–19], in recent
years, CxII (succinate: quinone oxidoreductase) has also been
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ular mechanism underlying mitochondrial ROS production regu-
lated by c-Src remains unknown, and further investigations are
needed to elucidate the roles of c-Src in the molecular functions
of mitochondria.
In the present study, we have identiﬁed ﬂotillin-1, an important
modulator of mitochondrial ROS production from the CxII system,
as target of Src. We further demonstrate that Tyr56 and Tyr149 of
ﬂotillin-1 are phosphorylated by mitochondrial c-Src, and that
these phosphorylations are required for its interaction with CxII
and for the suppression of ROS production. These ﬁndings suggest
that ﬂotillin-1 may be the component responsible for lowering ROS
production by c-Src.2. Materials and methods
2.1. Antibodies and chemicals
Mouse anti-FLAG M2 monoclonal antibody (mAb), mouse anti-
b-actin mAb, anti-FLAG M2 afﬁnity gel, hydroethidine (HE) and
20,70-dichloroﬂuorescin diacetate (H2DCFDA) were purchased from
Sigma (St. Louis, MO); rabbit polyclonal anti-SDHA antibody and
rabbit polyclonal anti-c-Src antibody were from Cell Signaling
Technology (Beverly, MA); rabbit polyclonal anti-SDHB antibody
and mouse anti-b-tubulin mAb were from Santa Cruz (Santa Cruz,
CA); mouse anti-cytochrome c mAb, mouse anti-ﬂotillin-1 mAb
and mouse anti-ﬂotillin-2 mAb were from BD Biosciences (San
Jose, CA); mouse anti-phosphotyrosine (4G-10) mAb was from
Millipore (Billerica, MA); Complex I and II Immunocapture beads
were from abcam (Cambridge, MA); MitoTracker Red regent and
Lipofectamine2000 were from Invitrogen (Carlsbad, CA); amino-
5-(4-chlorophenyl)-7-(t-butyl) pyrazolo [3,4d] pyrimidine (PP2)
was from Calbiochem (San Diego, CA); n-dodecyl-b-D-maltoside
(DDM) was from Dojindo (Kumamoto, Japan); FuGENE-HD was
from Roche (Madison, WI); sequencing grade modiﬁed trypsin
was from Promega (Madison, WI); k-protein phosphatase was
from New ENGLAND BioLabs (Beverly, MA); 9.25 MBq c[32P]ATP
was from Perkin Elmer (Waltham, MA); glutathione Sepharose
4B was from GE Healthcare (Buckinghamshire, England). All other
chemicals and regents were of the highest grade commercially
available.2.2. Cell cultures and plasmid transfection
Human T98G glioblastoma cells were cultivated in RPMI 1640
medium (Sigma) supplemented with 10% FBS in a humidiﬁed
atmosphere of 5% CO2 and 95% air at 37 C. Human retinal pigment
epithelial (RPE) cells were grown in DMEM/Nutrient Mixture F-12
Ham (Sigma) with 10% fetal bovine serum. Transfection was car-
ried out using FuGENE-HD according to the manufacturer’s recom-
mended protocol, and the cells were used for experiments 48 h
after transfection.
2.3. RNA interference
The small interfering RNA (siRNA) duplex speciﬁc for human c-
Src was obtained from greiner (Sedanstrasse, Germany). The siRNA
sequence for human c-Src (50-CUCGGCUCAUUGAAGACAAdTdT-30)
and scramble sequence for control (50-AGGUAGUGUAAUCGC-
CUUGdTdT-30) were designed as described [23]. To achieve gene
silencing, T98G cells were transfected with the siRNA for 4 days
using Lipofectamine2000 according to the manufacturer’s recom-
mended protocol, then the gene silencing effect was evaluated by
Western blotting analysis.2.4. Expression plasmid construction and mutagenesis
Full-length cDNAs for human ﬂotillin-1 and ﬂotillin-2 were
obtained by PCR using a human brain cDNA library, and their
sequences were conﬁrmed by BigDye sequencing (Applied Biosys-
tems, Carlsbad, CA) as described [9]. Tyr56 or Tyr149 in ﬂotillin-1
was replaced with Phe (Y56F-ﬂotillin-1 and Y149F-ﬂotillin-1)
using the primeSTAR mutagenesis kit (Takara, Shiga, Japan), and
conﬁrmed. The cDNAs for ﬂotillin-1, Y56F-ﬂotillin-1, Y149F-ﬂotil-
lin-1 and ﬂotillin-2 were subcloned into mammalian expression
plasmid pcDNA3 (Life Technologies) harboring a FLAG-tag at the
C terminus. For predominant expression in mitochondria, the
mitochondria-targeting sequence (MTS: residues 1–40 of the
amino acid sequence) of very long chain acyl-CoA dehydrogenase
(VLCAD) was fused to the N termini of C-FLAG-tagged ﬂotillin-1
and ﬂotillin-2. WT-c-Src-FLAG, MTS-WT-c-Src-FLAG, KD-(kinase
dead)-c-Src-FLAG (Lys298 in c-Src was replaced with Met) and
MTS-KD-c-Src-FLAG constructs were prepared as described [9].
For the expression of glutathione S-transferase (GST) fusion pro-
tein, ﬂotillin-1 was cloned into the pGEX-4T-1, as described above.
2.5. Preparation of the mitochondria-enriched fraction
Mitochondria were isolated from cultured cells by differential
centrifugation as described previously [9].
2.6. Western blotting and immunoprecipitation
Cell pellets or the mitochondria-enriched fraction were solubi-
lized in lysis buffer (PBS, pH 7.4, 1% DDM, 1 mM Na3VO4) contain-
ing aprotinin (10 lg/ml), leupeptin (10 lg/ml), and PMSF (1 mM).
After being incubating on ice for 30 min, the lysates were clariﬁed
by centrifugation at 12000g for 15 min. After protein determina-
tion by a Bio-Rad protein assay regent (Bio-Rad, Hercules, CA), the
supernatants (20 lg) were subjected to SDS/PAGE and transferred
to PVDF ﬁlter membranes (Millipore). The membranes were
blocked with 5% non-fat dry milk in TBS containing 0.05% Tween
20, and incubated with primary antibodies. Blots were probed with
either goat anti-mouse or anti-rabbit antibody coupled to HRP
(Bio-Rad), and the positive signals were visualized by ECL (Perkin
Elmer). To immunoprecipitate FLAG-tagged proteins, the superna-
tants were incubated with anti-FLAG M2 afﬁnity gel for 2 h,
washed with washing buffer (PBS, 0.05% DDM), and the precipi-
tated proteins were blotted with anti-phosphotyrosine antibody.
2.7. LC/MS/MS
The lysates of the mitochondria-enriched fraction were clariﬁed
by centrifugation at 100000g for 15 min. To immunoprecipitate
CxI and CxII, the supernatants were incubated with CxI or CxII
immunocapture beads for 2 h, respectively, andwashedwithwash-
ing buffer (PBS, pH 7.4, 0.05% DDM). The precipitated proteins were
reduced with Tris [2-carboxyethyl] phosphine (8 mM) at 55 C for
1 h, alkylated with iodoacetamide (15 mM) at room temperature
for 30 min in the dark, and then digested with trypsin (1:40) at
30 C for 12 h. The resultingpeptideswerepuriﬁedonaC18 spin col-
umn (Pierce), and then dried almost completely in a vacuum centri-
fuge, and resuspended in 20 lL of 0.1% formic acid in water for LC/
MS/MS. Liquid chromatography was performed on an Easy nanoLC
II system (Thermo Fisher Scientiﬁc, San Jose, CA) coupled to an Orbi-
trap Elite mass spectrometer (Thermo Fishier Scientiﬁc). The Prote-
ome Discoverer™ 1.3 software (Thermo Fishier Scientiﬁc) was used
to generate the peak lists of all acquired MS/MS spectra, and these
were then were automatically searched against the human SWISS-
PROT protein sequence database (Sprot.human.57.fasta; 22,643
entries) using the SEQUEST searching program.
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c-Src proteins recovered on an anti-FLAG M2 afﬁnity gel from
T98G cells expressing C-FLAG-tagged WT-c-Src and KD-c-Src were
incubated with or without 0.5 lg of GST fusion proteins in kinase
buffer consisting of 20 mM Hepes-NaOH, pH 7.4, 10 mM MgCl2
50 lM ATP, and 92.5 kBq c[32P]ATP in total volume of 40 ll at
30 C for 20 min as described [9]. A GST fusion protein containing
the full length of ﬂotillin-1 were expressed in Escherichia coli
and puriﬁed with glutathione Sepharose 4B. Phosphorylation of
the GST fusion protein was assessed by SDS/PAGE followed by
autoradiography.
2.9. Measurement of reactive oxygen species (ROS)
Mitochondrial H2O2 was detected using a ﬂuorescence probe
H2DCFDA with excitation at 504 nm and emission at 529 nm. The
mitochondria-enriched fraction prepared from T98G cells was
incubated with H2DCFDA (30 lM) using glutamate (5 mM) and
succinate (5 mM) as substrates. Cellular O2 was detected using a
ﬂuorescence probe hydroethidine (HE) [24]. Transfected T98G cells
were loaded with HE (50 lM), and the ﬂuorescence intensity of HE
was observed over 30 min using a spectroﬂuorophotometer VARI-
OSKAN FLASH (Thermo Fisher Scientiﬁc, Waltham, MA) with exci-
tation at 488 nm and emission at 567 nm [9].
3. Results and discussion
It has been demonstrated that c-Src is a key molecule in the
modulation of mitochondrial function [3–9]. To understand the
role of c-Src in the mitochondrial ROS production system, we stud-
ied whether H2O2 production is affected by PP2, a selective inhib-
itor of SFKs. H2O2 production was monitored using the ﬂuorescent
probe H2DCFDA. Glutamate and succinate were used as substrates
to drive CxI- and CxII-dependent electron transport, respectively.
As shown in Fig. 1A, treatment with PP2 for 1 h caused
dose-dependent increase in the amount of H2O2 produced in the
mitochondria-enriched fraction prepared from T98G cells, whilePP2 (μM)
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Fig. 1. Regulation of mitochondrial ROS production by c-Src. (A) The mitochondria-en
following incubation in the absence for presence of PP2 (1 or 10 lM) for 1 h using the
Notice that the addition of succinate (a driver of CxII-dependent electron transport) incre
dependent electron transport) had no effect. (B) Whole cell extracts prepared from T98G
anti-c-Src and anti-b-actin antibodies (upper). ROS production was measured in T98G c
(lower). The experiments were repeated three times, and representative results are sho
means and SE (⁄⁄P < 0.01, ⁄P < 0.05).incubation with succinate, but not glutamate, enhanced the
increased amount of H2O2 production even further. To conﬁrm
the enhancement of ROS production by inhibition of c-Src, we used
siRNA designed to speciﬁcally suppress c-Src expression and
another ﬂuorescent probe HE for the detection of .O2. The protein
content of c-Src was signiﬁcantly reduced by 40 nM c-Src siRNA in
T98G cells as compared with scrambled siRNA for control. Further-
more, this c-Src silencing signiﬁcantly enhanced .O2 production
(Fig. 1B). Given our previous ﬁndings that T98G cells expressing
MTS-KD-c-Src, a dominant negative form harboring the mitochon-
dria-targeting sequence (MTS) of VLCAD, produce signiﬁcantly
more .O2 as compared with cells expressing wild type c-Src [9],
mitochondrial c-Src may be responsible for the regulation of mito-
chondrial H2O2 production through a modiﬁcation of CxII. Several
lines of evidence demonstrate that the oxidation of succinate by
CxII makes a signiﬁcant contribution to the relatively high rate of
ROS production by intact mitochondria as compared with other
respiratory substrates including glutamate, malate and palmitoyl-
carnitine [22,25–27]. Our results also show that succinate, but not
glutamate, contributes to mitochondrial H2O2 production. In addi-
tion, PP2 produces a signiﬁcant enhancement in H2O2 production
even when a buffer containing no exogenous substrates is used.
It is possible that endogenous succinate contributes to mitochon-
drial H2O2 production.
CxII consists of four subunits that are encoded in the nuclear
genome: SDHA, a ﬂavoprotein subunit that contains FAD bound
covalently in the active site; SDHB, an iron-sulfur protein subunit
that contains a chain of three iron-sulfur clusters, [2Fe-2S], [4Fe-
4S], and [3Fe-4S]; and SDHC and SDHD, two transmembrane cyto-
chrome b heme subunits [28]. Genetic defects in CxII are associated
with clinical symptoms. Germline heterozygous mutations in
SDHA/B/C/D result in hereditary pheochromocytome-paragangli-
oma syndrome [29–32], and recent studies have suggested that
these mutations are associated with excessive mitochondrial ROS
production [33,34]. Biochemical studies, including the determina-
tion of the crystal structure of CxII [35], as well as the elucidation
of the reaction mechanism of succinate oxidation [36], have pro-
vided important information about how clinical phenotypes are**
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ﬂuorescent probe 20 ,70-dichlorodihydroﬂuorescein diacetate (H2DCFDA) at 30 lM.
ased the amounts of ROS produced while the addition of glutamate (a driver of CxI-
cells transfected with 40 nM c-Src siRNA or control for 4 days, were blotted with
ells suppressing c-Src expression using a ﬂuorescence probe HE for .O2 detection
wn. Statistical signiﬁcance was evaluated by Student’s t-test; data are expressed as
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Fig. 2. Interaction of ﬂotillin-1 and ﬂotillin-2 with CxII in mitochondria. (A) Whole
cells (WCE), mitochondrial (Mito) extracts, and cytoplasmic (Cyto) fractions
prepared from T98G and RPE cells, were blotted with anti-ﬂotillin-1, anti-ﬂotillin-
2, anti-cytochrome c and anti-b-tubulin antibodies. (B) Immunoprecipitates
obtained from T98G cells treated with either 10 lM PP2 or vehicle for 1 h were
incubated with anti-CxII antibody, subjected to SDS/PAGE and blotted with anti-
ﬂotillin-1 and anti-ﬂotillin-2 antibodies. Total mitochondrial proteins were ana-
lyzed using anti-SDHA antibody (bottom).
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about the mechanisms underlying ROS production by the CxII sys-
tem at the level of posttranslational modiﬁcation. Therefore, we
investigated CxII components by LC/MS/MS in order to identify
the molecular targets of CxII regulated by c-Src kinases. CxII was
puriﬁed from the mitochondria-enriched fraction prepared from
T98G cells treated with PP2 at 10 lM for 1 h using CxII immuno-
capture beads, and the protein components were subjected to
SDS/PAGE and silver gel staining (Fig. S1). Puriﬁed CxI was used
as negative control. When puriﬁed CxII was digested with trypsin
and the resulting peptides were analyzed by LC/MS/MS, 14 pro-
teins could be identiﬁed in each sample (Table 1). Interestingly,
not only were unique peptides for SDHA/B/C/D subunits a identi-
ﬁed, but those for ﬂotillin-1 and ﬂotillin-2 were also identiﬁed as
components of complex II. On the other hand, these peptides were
not detected in puriﬁed CxI. In addition, the peak areas for ﬂotillin-
1, ﬂotillin-2 and SDHD were markedly decreased when T98G cells
were treated with PP2. A previous study had provided evidence
that knockdown of the SDHD subunit does not lead to increased
ROS production despite a signiﬁcant reduction in the amount of
expressed SDHD protein in HEK293 cells [28]. Therefore, ﬂotillins
rather than SDHD might be involved in ROS production derived
from CxII.
To conﬁrm the above results, we examined the levels of ﬂotillin-
1 and ﬂotillin-2 in mitochondria prepared from human cell lines
including T98G and RPE. The protein contents of ﬂotillin-1 and ﬂo-
tillin-2 were twice as high or more in the mitochondria-enriched
fractions derived from the tested cells as compared with whole-cell
lysates (Fig. 2A). The same blots were also probed for cytochrome c
as a mitochondrial marker, and b-tubulin as a cytoplasmic marker.
We detected cytochrome c, but not b-tubulin, in the mitochondria-
enriched fractions. Flotillin-1 and ﬂotillin-2 were also detected in
puriﬁed CxII, and the contents of ﬂotillin-1 and ﬂotillin-2 in puri-
ﬁed CxII were markedly less when T98G cells were treated with
PP2 (Fig. 2B), suggesting that ﬂotillin-1 and ﬂotillin-2 interact with
CxII. Flotillins are generally used as marker proteins of lipid rafts
and are considered to be scaffolding proteins of lipid microdo-
mains [37]. In addition, they are involved in various cellular pro-
cesses including insulin signaling, T cell activation, phagocytosis,
epidermal growth factor signaling, neutrophil chemotaxis, and
the regrowth of neurons [37–40]. A recent study has demonstrated
that ﬂotillin-1 is present in mitochondria prepared from mouse
heart, suggesting its pivotal role in mitochondria [41]. We also
showed the expression of ﬂotillin-1 and ﬂotillin-2 in mitochondria
prepared from human cells and their interaction with CxII. Thus,Table 1
CxII interacting proteins as identiﬁed by LC/MS/MS. LC/MS/MS analysis was
performed using tryptic peptides of puriﬁed CxII prepared from T98G cells treated
with either vehicle or 10 lM PP2 for 1 h. Bold values indicate statistical differences
(p < 0.05) between peak area of PP2(-) and PP2(+).
Description Coverage
[PP2()]
Coverage
[PP2(+)]
Area
[PP2()]
Area
[PP2(+)]
Mw
(kDa)
SDHA 74.25 74.55 1.361E8 1.184E8 72.6
SDHB 61.79 61.79 7.883E7 7.984E7 31.6
SDHC 45.56 36.09 1.328E6 1.647E6 18.6
SDHD 27.67 27.67 2.691E6 1.546E6 17.0
Flotillin-2 25.33 16.36 7.431E5 4.740E5 41.7
GRP75 24.01 19.15 1.876E6 2.021E6 73.6
Flotillin-1 19.67 9.37 7.224E5 4.336E5 47.3
ATP5B 9.45 10.4 4.653E5 4.188E5 56.5
HSP60 4.19 12.22 5.351E5 6.873E5 61.0
PHB 3.68 11.76 3.638E5 4.136E5 29.8
ATP5A1 4.88 9.58 3.229E5 2.960E5 59.7
TUFM 5.75 9.07 4.017E5 3.479E5 49.5
ANT2 7.72 7.72 6.695E5 5.458E5 32.9
EMI5 8.43 8.43 5.733E6 6.600E6 19.6ﬂotillins are likely to be transferred into the mitochondrial inner
membrane despite the lack of MTS in their domains.
Since treatment with PP2 leads to a reduction in the interaction
of ﬂotillin with CxII, we examined tyrosine-phosphorylation of
mitochondrial ﬂotillin-1 and ﬂotillin-2. An anti-phosphotyrosine
antibody clearly detected tyrosine-phosphorylated ﬂotillin-1-FLAG
in immunoprecipitates prepared from T98G cells expressing MTS-
WT-ﬂotillin-1-FLAG, harboring the MTS of VLCAD (Fig. S2), and this
level was reduced in cells treated with PP2 (Fig. 3A). Similar results
were obtained using T98G cells expressing MTS-KD-c-Src (Fig. 3B)
and silencing c-Src expression (Fig. S3A). On the other hand, tyro-
sine-phosphorylated ﬂotillin-2-FLAG was not detected (data not
shown). To further verify tyrosine-phosphorylation of mitochon-
drial ﬂotillin-1, ﬂotillin-1-FLAG was prepared from the mitochon-
dria-enriched fraction derived from T98G cells expressing
MTS-WT-ﬂotillin-1-FLAG, and then reacted with k-protein phos-
phatase. This analysis conﬁrmedmitochondrial ﬂotillin-1 as a tyro-
sine-phosphorylated protein (Fig. S3B), suggesting that ﬂotillin-1 is
a physiological target for phosphorylation by c-Src. To determine
whether ﬂotillin-1 is actually phosphorylated by c-Src, we per-
formed in vitro kinase assay using puriﬁed preparations of a WT-
c-Src, a KD-c-Src and a GST fusion protein containing full length
of ﬂotillin-1. WT-c-Src phosphorylated the GST-ﬂotillin-1 protein
efﬁciently, but not the GST protein. In contrast, KD-Src did not
phosphorylate the GST-ﬂotillin-1 protein. These results suggest
that c-Src phosphorylates mitochondrial ﬂotillin-1. The sites of ﬂo-
tillin-1 phosphorylation by c-Src were analyzed using PhosphoMo-
tif Finder (http://www.hprd.org/PhosphoMotif_ﬁnder) as
described [42]. Tyr54 and Tyr149 of ﬂotillin-1 were selected as
phosphorylation targets of c-Src. The phosphorylation of ﬂotillin-
1 at Tyr54 or Tyr149 was examined by an in vivo assay using the
phosphorylation-defective mutants MTS-Y54F-ﬂotillin-1-FLAG
and MTS-Y149F-ﬂotillin-1-FLAG (Fig. S2). An anti-phosphotyrosine
antibody clearly detected tyrosine-phosphorylated ﬂotillin-1-FLAG
in immunoprecipitates prepared from the mitochondria-enriched
fraction derived from T98G cells expressing MTS-WT-ﬂotillin-1-
FLAG, whereas the band densities were reduced for cells express-
ing MTS-Y54F-ﬂotillin-1-FLAG or MTS-Y149F-ﬂotillin-1-FLAG
(Fig. 3D). A previous study has shown that SFK Fyn directly phos-
phorylates ﬂotillin-1 at Tyr160 and ﬂotillin-2 at Tyr163, both of
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Fig. 3. Effect of ﬂotillin-1 phosphorylation on its interaction with CxII in mitochondria. Immunoprecipitates of T98G cells expressing MTS-WT-ﬂotillin-1 treated with 10 lM
PP2 or vehicle for 1 h (A) or co-expressed with MTS-WT-c-Src or MTS-KD-c-Src (B) were applied to an anti-FLAG M2 afﬁnity gel, separated by SDS/PAGE, and blotted with
anti-FLAG and anti-phosphotyrosine antibodies. An aliquot of GST-ﬂotillin-1 or GST (0.5 lg protein) was reacted with WT-c-Src or KD-c-Src (C) in kinase buffer containing
c[32P]ATP for 20 min at 30 C, separated by SDS/PAGE, and subjected to autoradiography (upper). Proteins were visualized by Coomasie brilliant blue staining (middle) or
blotted with anti-FLAG antibody (lower). Immunoprecipitates of the mitochondria-enriched fraction prepared from T98G cells expressing the indicated WT and mutants
proteins (D) were applied to an anti-FLAG M2 afﬁnity gel, separated by SDS/PAGE, and blotted with anti-FLAG, anti-SDHB and anti-phosphotyrosine antibodies.
M. Ogura et al. / FEBS Letters 588 (2014) 2837–2843 2841which are required for ﬂotillin internalization and the endocytic
process. In addition, c-Src also phosphorylates ﬂotillin-1 and ﬂotil-
lin-2 in vitro, but at other sites, implying that c-Src targets differ-
ent tyrosine residues [43]. Our results also demonstrate that
mitochondrial ﬂotillin-1, but not ﬂotillin-2, undergoes tyrosine
phosphorylation, and that this phosphorylation is attenuated by
treatment with PP2 and k-protein phosphatase. In addition,
Tyr56 and Tyr149 on ﬂotillin-1 are the predicted c-Src targets,
and the mutation of these residues to phenylalanine reduces phos-
phorylation. However, a recent study has suggested that PP2 sig-
niﬁcantly inhibits other tyrosine kinases including ErbB2 and
ErbB3 [44]. In this study, we demonstrated that phosphorylation
of mitochondrial ﬂotillin-1 is reduced by the expression of MTS-
KD-c-Src and the suppression of c-Src expression, and that puriﬁedc-Src directly phosphorylates ﬂotillin-1 in vitro. Thus, it is conceiv-
able that c-Src phosphorylates ﬂotillin-1 at Tyr56 and Tyr149.
To assess the effect of Tyr56 and Tyr149 in mitochondrial ﬂotil-
lin-1 on the interaction with CxII, the content of SDHB in immuno-
precipitates prepared from the mitochondria-enriched fraction
derived from T98G cells expressing MTS-WT-ﬂotillin-1-FLAG,
MTS-Y54F-ﬂotillin-1-FLAG or MTS-Y149F-ﬂotillin-1-FLAG was
examined. We detected SDHB in immunoprecipitates prepared
from the mitochondria-enriched fraction derived from T98G cells
expressing MTS-WT-ﬂotillin-1-FLAG, whereas the band was
reduced for cells expressing MTS-Y54F-ﬂotillin-1-FLAG or MTS-
Y149F-ﬂotillin-1-FLAG (Fig. 3D). These results suggest that ﬂotil-
lin-1 interacts with CxII through its phosphorylation at Tyr56
and Tyr149. Several reports have suggested that ﬂotillins interact
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Fig. 4. Effect of ﬂotillin-1 phosphorylation on ROS production. H2O2 (A) and .O2 (B) production in T98G cells expressing WT and phosphorylation defective mutants was
measured. Mitochondrial fractions were incubated for 30 min with the ﬂuorescent probe H2DCFDA for H2O2 detection in the presence of 5 mM succinate as a respiratory
substrate. Cells were incubated for 30 min with a ﬂuorescence probe HE. The experiments were repeated three times, and representative results are shown. Statistical
signiﬁcance was evaluated by Student’s t-test; data are expressed as means and SE (⁄⁄P < 0.01).
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lational modiﬁcations including phosphorylation, myristylation
and palmitoylation, and that ﬂotillins physically interact with each
other to form heterooligomeric complexes through coiled-coil
domains at their C termini [45,46]. Our results also demonstrate
that ﬂotillin-1 is phosphorylated on a conserved tyrosine residue,
Tyr56 or Tyr149, in its highly conserved prohibitin homology
domain that is essential for its interaction with CxII. Preliminary
immunoprecipitation assay results demonstrate that the mutation
of Tyr215 in SDHA to phenylalanine reduces its interaction with
ﬂotillin-1 and ﬂotillin-2 (Fig. S4). It is possible that the phosphor-
ylation of these targets by c-Src is required for this interaction. Fur-
ther studies on the molecular conformations of these sites are
required to clarify the exact mechanisms by which their phosphor-
ylation affects the interaction with CxII.
The effects of the phosphorylation of mitochondrial ﬂotillin-1 at
Tyr56 and Tyr149 on H2O2 production were examined using H2-
DCFDA. As shown in Fig. 4A, a signiﬁcant enhancement in the
amount of H2O2 was observed in T98G cells expressing MTS-
Y54F-ﬂotillin-1-FLAG or MTS-Y149F-ﬂotillin-1-FLAG as compared
with WT cells. In addition, similar results were obtained using
HE (Fig. 4B). These results suggest that the phosphorylation of
mitochondrial ﬂotillin-1 at Tyr56 and Tyr149 is important for efﬁ-
cient electron transfer in CxII and the prevention of ROS produc-
tion. Pharmacological studies using respiratory complex
inhibitors have demonstrated that a number of possible sites
may be involved in ROS production, in particular the FAD site on
CxII, ubiquinone sites on CxI and CxIII, and the FMN site on CxI dur-
ing succinate oxidation [47]. At these sites, it has been generally
accepted that reverse electron transport into the ubiquinone site
of CxI is associated with the mechanism of ROS production,
because the ROS production is inhibited by treatment with rote-
none, a classic ubiquinone site inhibitor of CxI [34,48]. However,
recent studies suggest that a fully reduced or semi-reduced FAD
in CxII is the relevant ROS producer, producing H2O2 or O2 during
two-electron or one-electron oxidation, respectively [22,35]. Our
previous study also demonstrated that the phosphorylation of
SDHA at Tyr215 plays an important role in the prevention of ROS
production, and that Tyr215 locates in the FAD-binding domainbetween FAD in SDHA and an iron-sulfur cluster in SDHB [9]. In
addition, our present results show that the phosphorylation of
SDHA at Tyr215 is required for the interactions with ﬂotillin-1
and ﬂotillin-2. Thus, it is conceivable that ﬂotillins may interact
with SDHA, and that the prevention of ROS production by ﬂotillin
interaction may be due to an interruption of a direct reaction
between oxygen and .FADH or FADH2.
Taken together, we conclude that mitochondrial c-Src phos-
phorylates ﬂotillin-1 at Tyr56 and Tyr149, and that these phospho-
rylations are required for its interaction with CxII and the
prevention of ROS production. To our knowledge, this is the ﬁrst
direct demonstration of a critical role for ﬂotillin-1 in mitochon-
dria. These ﬁndings also provide a clue to understanding novel
mechanisms for ROS production related to CxII in mitochondria.
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